Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 12510Q100 since 12/18/2024, newest first.
| Filer | % of Class | Filed | |
|---|---|---|---|
| Price T Rowe Associates Inc /MD/ 13G/A Amendment 1 | 7.5% |
8/14/2026
Event 6/30/2026
|
|
| Principal Global Investors 13G/A Amendment 1 | 0% |
8/5/2026
Event 6/30/2026
|
|
| Vanguard Capital Management LLC 13G/A Amendment 1 | 4.95% |
7/31/2026
Event 6/30/2026
|
|
| Akre Capital Management, LLC 13G | 5.2% |
5/15/2026
Event 3/31/2026
|
|
| Price T Rowe Associates Inc /MD/ 13G | 5.5% |
5/15/2026
Event 3/31/2026
|
|
| Vanguard Portfolio Management LLC 13G | 5.9% |
4/29/2026
Event 3/31/2026
|
|
| Vanguard Capital Management LLC 13G | 5.0% |
4/29/2026
Event 3/31/2026
|
|
| Vanguard Group Inc 13G/A Amendment 4 | 0% |
3/26/2026
Event 3/13/2026
|
|
| T. Rowe Price Investment Management, Inc. 13G/A Amendment 3 | 3.4% |
3/6/2026
Event 2/28/2026
|
|
| T. Rowe Price Investment Management, Inc. 13G/A Amendment 2 | 11.6% |
2/17/2026
Event 12/31/2025
|
|
|
Advent International, L.P.
13D/A
Amendment 11
|
0% |
11/12/2025
Event 11/7/2025
|
|
| Advent International, L.P. | 0% | ||
| Advent International GP, LLC | 0% | ||
| Advent International Gpe VIII, LLC | 0% | ||
| Cypress Investor Holdings, L.P. | 0% | ||
| Advent International Gpe VIII-C Limited Partnership | 0% | ||
| Gpe VIII CCC Co-Investment (Delaware) Limited Partnership | 0% | ||
| Cypress Investment GP, LLC | 0% | ||
| Gpe VIII GP S.A.R.L | 0% | ||
| Gpe VIII GP Limited Partnership | 0% | ||
| Principal Global Investors 13G | 5.6% |
11/6/2025
Event 9/30/2025
|
|
| Vanguard Group Inc 13G/A Amendment 3 | 10.0% |
9/8/2025
Event 8/29/2025
|
|
|
Advent International, L.P.
13D/A
Amendment 10
|
5.7% |
8/8/2025
Event 8/7/2025
|
|
| Advent International, L.P. | 5.7% | ||
| Advent International GP, LLC | 5.7% | ||
| Advent International Gpe VIII, LLC | 1.5% | ||
| Cypress Investor Holdings, L.P. | 4.2% | ||
| Advent International Gpe VIII-C Limited Partnership | 0.1% | ||
| Gpe VIII CCC Co-Investment (Delaware) Limited Partnership | 1.4% | ||
| Cypress Investment GP, LLC | 4.2% | ||
| Gpe VIII GP S.A.R.L | 0.1% | ||
| Gpe VIII GP Limited Partnership | 1.4% | ||
| Vanguard Group Inc 13G/A Amendment 2 | 9.1% |
7/29/2025
Event 6/30/2025
|
|
|
Advent International, L.P.
13D/A
Amendment 9
|
10.2% |
5/22/2025
Event 5/20/2025
|
|
| Advent International, L.P. | 10.2% | ||
| Advent International GP, LLC | 10.2% | ||
| Advent International Gpe VIII, LLC | 2.7% | ||
| Cypress Investor Holdings, L.P. | 7.5% | ||
| Advent International Gpe VIII-C Limited Partnership | 0.2% | ||
| Gpe VIII CCC Co-Investment (Delaware) Limited Partnership | 2.5% | ||
| Cypress Investment GP, LLC | 7.5% | ||
| Gpe VIII GP S.A.R.L | 0.2% | ||
| Gpe VIII GP Limited Partnership | 2.5% | ||
|
Advent International, L.P.
13D/A
Amendment 8
|
15.0% |
4/2/2025
Event 3/3/2025
|
|
| Advent International, L.P. | 15.0% | ||
| Advent International GP, LLC | 15.0% | ||
| Advent International Gpe VIII, LLC | 4.0% | ||
| Cypress Investor Holdings, L.P. | 11.0% | ||
| Advent International Gpe VIII-C Limited Partnership | 0.3% | ||
| Gpe VIII CCC Co-Investment (Delaware) Limited Partnership | 3.6% | ||
| Cypress Investment GP, LLC | 11.0% | ||
| Gpe VIII GP S.A.R.L | 0.3% | ||
| Gpe VIII GP Limited Partnership | 3.6% |
| Period | Filings | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q3 | 9 | 6.38 M | $42.5 M |
| 2026 Q2 | 360 | 626 M | $3.85 B |
| 2026 Q1 | 381 | 623 M | $3.74 B |
| 2025 Q4 | 353 | 736 M | $5.86 B |
| 2025 Q3 | 363 | 702 M | $6.40 B |
| 2025 Q2 | 346 | 683 M | $6.43 B |
| 2025 Q1 | 347 | 655 M | $6.05 B |
| 2024 Q4 | 317 | 633 M | $7.42 B |
| 2024 Q3 | 306 | 625 M | $6.90 B |
| 2024 Q2 | 317 | 612 M | $6.79 B |
| 2024 Q1 | 274 | 600 M | $7.17 B |
| 2023 Q4 | 249 | 589 M | $6.71 B |
| 2023 Q3 | 204 | 621 M | $8.28 B |
| 2023 Q2 | 175 | 616 M | $6.90 B |
| 2023 Q1 | 157 | 608 M | $5.45 B |
| 2022 Q4 | 141 | 603 M | $5.24 B |
| 2022 Q3 | 120 | 606 M | $5.51 B |
| 2022 Q2 | 104 | 593 M | $5.46 B |
| 2022 Q1 | 74 | 593 M | $6.55 B |
| 2021 Q4 | 74 | 582 M | $6.63 B |
| 2021 Q3 | 69 | 520 M | $5.47 B |
| 2021 Q2 | 1 | 3.50 M | $34.9 M |